Yeah this isn't really going to do that well. I kind of view REGN's Phase 3 VELOUR trial results the same way; stat significant p-values, but clinically relevant? Maybe not.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.